share_log

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

CooperCompanies將在J.P. Morgan醫療會議上發表演講
GlobeNewswire ·  2024/12/17 16:15

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.

加利福尼亞州聖拉蒙,2024年12月17日(全球新聞通訊)-- CooperCompanies(納斯達克:COO),一家領先的器械公司,今天宣佈將參加於2025年1月14日星期二舉行的J.P.摩根醫療會議。公司總裁兼首席執行官阿爾·懷特將在預計於東部時間下午6:00開始的會議中代表公司。

A live and archived webcast of this event, where applicable, will be available by accessing the CooperCompanies' website at .

有關本次活動的直播和存檔網頁,在適用的情況下,可通過訪問CooperCompanies的網站獲取。

About CooperCompanies

關於CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women's health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies ("Cooper") has a workforce of more than 16,000 with products sold in over 130 countries. For more information, please visit .

CooperCompanies(納斯達克:COO)是一家領先的全球器械公司,致力於改善人們的生活。公司通過兩個業務部門運營,分別是CooperVision和CooperSurgical。CooperVision是隱形眼鏡行業的可信賴領導者,每天改善數百萬人的視力。CooperSurgical是一家領先的生育和女性健康公司,致力於在最重要的醫療時刻協助女性、嬰兒和家庭。CooperCompanies(「Cooper」)總部位於加利福尼亞州聖拉蒙,擁有超過16,000名員工,產品銷售至130多個國家。欲了解更多信息,請訪問。

Contact:

聯繫:

Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com

金·鄧肯
副總裁,投資者關係與風險管理
925-460-3663
ir@cooperco.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論